sick - Brit May Govt Backs Sex-Change Treatment
for Under
sick - Brit May Govt Backs Sex-Change Treatment
for Under 16s, Snubs Christian Group < >
Theresa May’s health secretary has snubbed Christian campaigners and backed the use of sex-change drugs for children under the age of 18.
The Department of Health and Social Care, led by Jeremy Hunt MP, said that young people have a right “to determine what happens to their own bodies,” including consenting to drug treatments that can sterilise them and stunt growth.
It comes as the Government considers a 2016 parliamentary report demanding “trans issues” are “mandatory” on school curriculums, 16-year-olds can change their gender without parental consent, and calling for “fast-tracked” sex changes.
Hunt’s department was responding to a petition by the Christian group Voice for Justice UK, signed by more than 8,000 people, which called for all surgical and hormonal sex-change treatment to “be banned below the age of 18.”
The group referenced recent reports revealing the number of people regretting and seeking to reverse sex-change procedures is sharply rising, and criticised the fact children as young as four are being encouraged to embrace transgender ideology in school – something first exposed by Breitbart in 2015.
“The inevitable result is that increasing numbers of children are seeing themselves as having been born in ‘the wrong body’ and are demanding treatment,” the petition, addressed directly to Jeremy Hunt, says.
Prohibit all medical treatment for gender reassignment below the age of 18
With increasing reports of people seeking reversal of gender reassignment surgery (see recent report in The Independent, http://www.independent.co.uk/life-style/gende...demand-r... ;...
Indeed, studies have found that 70 to 80 per cent of children who “feel” transgender lose such feelings, and another concluded that such feelings are much more likely to persist when adults in authority, such as teachers, tell kids they could be in the wrong body.
This government response is uninformed: puberty blockers may be given at age 10. If a child progresses to cross-sex hormones at 16 (as over 90% do) they are sterilised. Is this in a child's best interests? @DHSCgovuk @Jeremy_Hunt https://www.gov.uk/government/news/voice-for-...assignment …
However, Hunt’s department wrote that “if children have the capacity to give consent for themselves, then consent should be sought direct from them.”
A person under 16 can consent to a sex change procedure “if they have ‘sufficient understanding and intelligence to enable him or her to understand fully what is proposed’,” they claim.
Furthermore, controversial sex-change drugs can be prescribed “generally once the patient is around 15 years old for hormone blockers and 16 years old for cross-sex hormones.”
The petitioners had concluded their appeal by asking: “If a young person cannot legally buy a glass of beer below the age of 18, how is it we encourage them to make life-changing decisions involving the surgical mutilation of an otherwise healthy body, lifelong infertility, and with a lifetime spent on sex change hormones carrying well documented health risks and shortening life expectancy?”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fresh Face at the Helm Hiring Mark McSpadden as Chief Product Officer is a move by FCM Travel that signals the company's intent to deepen its roots in tech and innovation within the corporate travel sector. There's no subtlety here—FCM's making a bold statement, and they're throwing serious weight behind their tech strategy. Don’t take this lightly; this is them...
Continue Reading
Granite Industry: Chunks of Opportunity Throw a rock, and you’re bound to hit a project that’s using granite somewhere. The market for this tough-as-nails natural stone is projected to grow to USD 24.03 billion by 2031, up from USD 18.94 billion in 2025. That’s according to Mordor Intelligence, which says we’re looking at a 4.25% CAGR during 2026-2031....
Continue Reading
Outbreak Strikes Again: Legal Actions Escalate In the world of food safety, calamities tend to cluster, and this latest case is another striking example. The Little Wicomico River oyster incident is spiraling into a classic courtroom drama with the filing of a second lawsuit. A Maryland man, Jonathan Rucker, has added fuel to the fire with his federal court filing after...
Continue Reading
Aristocrat's Upcoming Change at the Helm Shuffling the deck at the top can make or break a ship. Aristocrat is swapping its captain as Trevor Croker steps down, and they're betting Dafne Guisard's got the wind in her sails to ride the next wave. This ain't your average CEO transition, either—it's got a whole year of easing into the reins. The Decision to Appoint Guisard...
Continue Reading
Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...
Continue Reading
Innovation in Orthopaedic Surgery Recognized There's a fresh breeze blowing in the world of orthopaedic hip and knee surgery, and its name is THINK Surgical. The company's latest gadget, the TMINI® Miniature Robotic System, just snagged the 2026 Industry Innovation Award from the American Association of Hip and Knee Surgeons (AAHKS). It's like the Oscars for joints,...
Continue Reading
Improving Poland's Emergency Response These days, storms, fires, and floods seem relentless, each disaster knocking harder on the doors of communities worldwide. But Poland's upping the ante, thanks to ICEYE teaming up with Civil Security Hub Poland (CS Hub PL). In an era where data is every bit as crucial as the fire trucks, this partnership is like the cavalry for...
Continue Reading
Lucas Bols: A Legacy Crowned A 450-year-old legacy finally gets its due with the Lucas Bols Company snagging the "Spirit Brand of the Year" title from Wine Enthusiast. This ain’t just another pat on the back; it's a serious nod to a brand that’s been laying down the cocktail foundation long before some countries even existed. Across the past five centuries, they've...
Continue Reading
Navigating the Insurance Labyrinth Buckle up! We're diving into the tangled web of dental insurance verification—a task as irritating as it is necessary in the world of dental practices. Introducing FlexVerification, a freshly minted tool from Flex Dental Solutions, designed to cut through the quagmire of insurance checks. Their target? Dentists using Open Dental...
Continue Reading
When the reaper comes knocking, families are left juggling grief and logistics—it ain't easy. Jake Leonetti from Lewis Funeral Chapel in Bremerton, Washington, has been in the trenches long enough to know the drill. His insights might just make those funeral arrangements a bit smoother, so let's cut to the chase. First Order of Business: Contact a Funeral Director First...
Continue Reading
Top 5 Most Recently Viewed Articles
Upcoming Shareholders Meeting of Cellcom Israel Ltd. Cellcom Israel Ltd. (TASE: CEL) is set to hold an important Annual General Meeting. This gathering aims to discuss significant company matters, ensuring all shareholders have their voices heard and their rights protected. Date and Location The meeting will take place at 15:00 p.m. (local time), allowing shareholders to...
Continue Reading
Growth of the In-Vitro Toxicology Testing Market to $57.55 Billion The in-vitro toxicology testing market had a valuation of US$ 26.00 billion in 2024 and is anticipated to expand significantly, reaching US$ 57.55 billion by 2033. This remarkable growth is attributed to a compound annual growth rate (CAGR) of 9.23%, a trend fueled by heightened ethical standards and...
Continue Reading
Overview of the Testing, Inspection, and Certification Market The Testing, Inspection, and Certification (TIC) market has become essential for ensuring product quality, safety, and regulatory compliance across a variety of industries. As of 2023, the market was valued at around USD 302.52 billion and is expected to experience substantial growth, reaching approximately USD...
Continue Reading
Integer Holdings Corporation Announces Conversion Period for Notes Integer Holdings Corporation (NYSE: ITGR), a prominent medical device contract development and manufacturing organization, has officially announced the conversion period for its 2.125% Convertible Senior Notes due in 2028. This window for conversion begins on April 1, 2025, and will end on June 30, 2025....
Continue Reading
Understanding Telix Pharmaceuticals' Legal Situation Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is currently facing a challenging period due to regulatory scrutiny that has raised concerns among investors. The implications of this situation are significant, as they involve vital issues related to the company's operations and market performance. As developments unfold,...
Continue Reading